Miragen Therapeutics shares owned by Fairmount Funds Management
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Fairmount Funds Management
from 13F filings
Historical chart of Fairmount Funds Management investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Fairmount Funds Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $30M | 1.4M | 21.78 |
| 2023-09-30 | $21M | 1.4M | 15.34 |
| 2023-06-30 | $33M | 1.4M | 23.79 |
| 2023-03-31 | $35M | 1.4M | 25.44 |
| 2022-12-31 | $40M | 1.4M | 29.21 |
| 2022-09-30 | $28M | 1.4M | 20.51 |
| 2022-06-30 | $11M | 944k | 11.57 |
| 2022-03-31 | $18M | 944k | 18.49 |
| 2021-12-31 | $19M | 944k | 19.77 |
| 2021-09-30 | $16M | 944k | 16.45 |
| 2021-06-30 | $642k | 35k | 18.29 |
| 2021-03-31 | $581k | 35k | 16.56 |
More positions owned by Fairmount Funds Management
View all positions for Fairmount Funds Management